25 related articles for article (PubMed ID: 37335232)
1. The role of systemic inflammatory response index (SIRI) and tumor-infiltrating lymphocytes (TILs) in the prognosis of patients with laryngeal squamous cell carcinoma.
Wang T; Zhang D; Tang D; Heng Y; Lu LM; Tao L
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5627-5636. PubMed ID: 36520215
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy enhances tumor-specific T cell immunity in patients with HPV-associated oropharyngeal cancer.
Samaniego C; Friedman J; Yang X; Badger C; Shaver T; Samankan S; Thakkar P; Goodman J; Joshi A; Allen CT
Head Neck; 2023 Sep; 45(9):2294-2302. PubMed ID: 37480219
[TBL] [Abstract][Full Text] [Related]
3. Single-cell RNA sequencing reveals pro-invasive cancer-associated fibroblasts in hypopharyngeal squamous cell carcinoma.
Cai Z; Chen L; Chen S; Fang R; Chen X; Lei W
Cell Commun Signal; 2023 Oct; 21(1):292. PubMed ID: 37853464
[TBL] [Abstract][Full Text] [Related]
4. An algorithm for standardization of tumor Infiltrating lymphocyte evaluation in head and neck cancers.
Xirou V; Moutafi M; Bai Y; Nwe Aung T; Burela S; Liu M; Kimple RJ; Shabbir Ahmed F; Schultz B; Flieder D; Connolly DC; Psyrri A; Burtness B; Rimm DL
Oral Oncol; 2024 May; 152():106750. PubMed ID: 38547779
[TBL] [Abstract][Full Text] [Related]
5. Establishment and characterization of a novel hypopharyngeal squamous cell carcinoma cell line CZH1 with genetic abnormalities.
Ma J; Zhu X; Heng Y; Ding X; Tao L; Lu L
Hum Cell; 2024 Mar; 37(2):546-559. PubMed ID: 38280070
[TBL] [Abstract][Full Text] [Related]
6. Unveiling the Association between HPV and Pan-Cancers: A Bidirectional Two-Sample Mendelian Randomization Study.
Sun J; Xiang J; An Y; Xu J; Xiong Y; Wang S; Xia Q
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958321
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Relevance of Tumor-Infiltrating Immune Cells in Cervix Squamous Cell Carcinoma.
Wild CM; Garrido F; Dannecker C; Köpke MB; Chateau MC; Boissière-Michot F; Heidegger HH; Vattai A; Kessler M; Jeschke U; Cavaillès V
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894319
[TBL] [Abstract][Full Text] [Related]
8. [The tumor microenvironment-relay station for prognosis and therapy response].
Krupar R
Pathologie (Heidelb); 2022 Aug; 43(Suppl 1):141-147. PubMed ID: 36414699
[TBL] [Abstract][Full Text] [Related]
9. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
[TBL] [Abstract][Full Text] [Related]
10. HPV16 status might correlate to increasing tumor-infiltrating lymphocytes in hypopharyngeal cancer.
Ji M; Lin L; Huang Q; Hu C; Zhang M
Acta Otolaryngol; 2023; 143(6):543-550. PubMed ID: 37335232
[TBL] [Abstract][Full Text] [Related]
11. The presence of tumour-infiltrating lymphocytes (TILs) and the ratios between different subsets serve as prognostic factors in advanced hypopharyngeal squamous cell carcinoma.
Wang J; Tian S; Sun J; Zhang J; Lin L; Hu C
BMC Cancer; 2020 Aug; 20(1):731. PubMed ID: 32758195
[TBL] [Abstract][Full Text] [Related]
12. Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.
Hu C; Tian S; Lin L; Zhang J; Ding H
Oral Oncol; 2020 Mar; 102():104560. PubMed ID: 31923855
[TBL] [Abstract][Full Text] [Related]
13. Immune related proteins and tumor infiltrating CD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome.
Landin D; Ährlund-Richter A; Mirzaie L; Mints M; Näsman A; Kolev A; Marklund L; Dalianis T; Munck-Wikland E; Ramqvist T
Head Neck; 2020 Nov; 42(11):3206-3217. PubMed ID: 32613643
[TBL] [Abstract][Full Text] [Related]
14. Correlation of immune makers with HPV 16 infections and the prognosis in oropharyngeal squamous cell carcinoma.
Zhu Y; Zhu X; Diao W; Liang Z; Gao Z; Chen X
Clin Oral Investig; 2023 Apr; 27(4):1423-1433. PubMed ID: 36884083
[TBL] [Abstract][Full Text] [Related]
15. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors.
de Ruiter EJ; de Roest RH; Brakenhoff RH; Leemans CR; de Bree R; Terhaard CHJ; Willems SM
Cancer Immunol Immunother; 2020 Apr; 69(4):581-591. PubMed ID: 31980916
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]